"I'm proud to have been awarded the 2025 Hartwig Piepenbrock-DZNE Prize. Being able to give hope and contribute to the treatment of patients affected by Alzheimer's disease is what has driven me ...

In this uncontrolled environment, the pathological cascade of Alzheimer’s begins, with the formation of beta-amyloid protein ...

June is Brain and Alzheimer’s Awareness Month — a chance to examine real-world data that links new treatments to changing clinical behavior.

A newly approved Alzheimer’s drug is set to be administered for the first time in Taiwan on Monday, Far Eastern Memorial Hospital in New Taipei City announced yesterday. Kisunla, the brand name of the ...

INmune Bio's XPro1595 targets soluble TNF for Alzheimer's. Phase 2 results could reshape inflammatory disease treatment.

Drugs that slow progression of Alzheimer’s don’t provide enough benefit to justify substantial cost for NHS, regulator has ...

Few people in the UK with early stage Alzheimer's disease are likely to be suitable for the latest drugs which aim to halt progress of the condition, yet many are nevertheless likely to be referred ...

Some protein bars are so delicious, they double as candy bars. And some protein bars are so delicious, because they are candy bars – or at least backed by candy bar companies. This week, Hershey’s ...

In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, accessible and inexpensive than other existing tests.

Of the patients tested, blood biomarkers positively identified Alzheimer's in 267 individuals. Specifically, 233 out of 246 patients with Alzheimer’s-related cognitive impairment (95%) had ...